Multiple Sclerosis International

Multiple Sclerosis International / 2021 / Article

Research Article | Open Access

Volume 2021 |Article ID 8874999 | https://doi.org/10.1155/2021/8874999

Omid Mirmosayyeb, Mahdi Barzegar, Alireza Afshari-Safavi, Nasim Nehzat, Afshin Heidari, Parisa Emami, Vahid Shaygannejad, "Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS)", Multiple Sclerosis International, vol. 2021, Article ID 8874999, 7 pages, 2021. https://doi.org/10.1155/2021/8874999

Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS)

Academic Editor: Pasquale Calabrese
Received05 Sep 2020
Revised13 Mar 2021
Accepted04 Jun 2021
Published10 Jun 2021

Abstract

Introduction. Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMO) are chronic immune-mediated diseases in the central nervous system (CNS). Environmental factors such as month of birth can be a trigger for these diseases. Therefore, we conducted this study to compare the months of birth in MS and NMOSD patients with the control group. Methods. In this cross-sectional study, 2345 patients with MS, 220 NMOSD patients, and 2174 healthy subjects were enrolled. Demographic information such as age, sex, month of birth, and education in three groups was extracted from the database. The associations between month of birth and MS were studied by binary logistic regression with adjusting for the year of birth. Results. There was a reduced birth rate in September-October in NMOSD (, 95% CI: 0.150-0.636; ) and MS patients (, 95% CI: 0.374-0.591; ) compared to the general population. The birth rate in March-April in MS was higher than the control group (, 95% CI: 1.324-1.964; ). There was no difference in the birth month distribution between the NMOSD and MS patients. No significant difference in MOB among different MS types was found. Conclusion. Our findings showed a decreasing risk of NMOSD and MS in individuals born in the autumn months and an increasing MS risk in spring. More studies are required to elucidate the association between the month of birth and risk of MS and NMOSD and the seasonality factors.

1. Introduction

Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are chronic inflammatory diseases that involve the central nervous system (CNS) [1]. For many years, NMOSD was considered a variant of MS; however, discovering a disease-specific serum NMO-immunoglobulin G (IgG) antibody helped distinguish between these diseases [2]. More studies on clinical course, immunological features, and imaging findings provide clear evidence on differences between NMOSD and MS. Today, NMOS and MS are known as two distinct diseases [35].

The exact etiology of NMOSD and MS is still unclear. The interaction between genetic and environmental factors has been implicated as the probable underlying MS etiologies [6]. Environmental factors such as childhood residence, migration in early adolescence, and the distance of the place from the equator have an essential role in developing MS [79]. The last two decades have seen a growing trend towards the month of birth’s (MoB) effect on the risk of autoimmune diseases [1012]. However, the debate continues about the influence of MoB on the risk of MS in adulthood. Some studies showed an association between spring births and MS susceptibility [1214]. On the other hand, there is some evidence on increasing MS risk in individuals born in the winter months and a protective effect when born in the autumn [1517]. Some investigation results showed no difference in the month of birth pattern between MS and the general population [18, 19]. Moreover, some studies were confounded by some variables such as years and place of birth [20, 21].

Until now, far too little attention has been paid to the distribution of birth months within the NMOSD population. NMOSD has a strong association with other autoimmune disorders and shares similar triggers for the immune-mediated process. It can be hypothesized an association between MoB and NMOSD. Therefore, we set out this study to determine birth months’ distribution in Iranian patients with NMOSD and MS and compare with the general population.

2. Methods

Data on the month and year of birth of 2565 patients with MS and NMOSD were extracted from the Isfahan Hakim MS database [22]. All patients were visited in the MS clinic of Kashani hospital, affiliated to Isfahan University of Medical Sciences, Isfahan, Iran. Diagnosis of MS and NMOSD was made by a neurologist with subspecialty training in MS (VS), based on McDonald criteria [2325] or International consensus NMOSD diagnostic criteria [26]. Demographic and clinical information, including age, sex, marital status, education levels, number of relapses within the previous year, disease severity, and MS course, were extracted. The severity of diseases (both NMOSD and MS) was measured using the Expanded Disability Status Scale (EDSS) score [27].

The control data were extracted from two main healthcare networks of Isfahan city (number 1 and 2) attending the Isfahan University of Medical Sciences. Five centers affiliated at the healthcare network 1 and the latter five affiliated at the healthcare network 2 randomly were selected from the different urban areas using Random Allocation software. Therefore, each of the centers was provided with a particular code. Eventually, the information of 2174 healthy people was retrieved through a random selection of the participant based on their family code. Demographic data, including age, sex, marital status, education levels, medical history, month, and year of birth, were extracted. The exclusion criteria for both groups were diagnosis of autoimmune or neurological diseases rather than MS and NMOSD. This study was approved by the Ethics Committee of Isfahan University of Medical Sciences (Ethics code number IR.MUI.MED.REC.1398.403).

The obtained data were entered into the Statistical Package for Social Sciences (SPSS) version 25. The descriptive data were presented in mean, standard deviation, absolute numbers, and percentages. The chi-square test and independent -test (or Mann–Whitney) were utilized for comparison between groups. The associations between month of birth and MS were studied by binary logistic regression with adjusting for the year of birth. Significance level after correcting with Bonferroni was .

3. Results

The information of 5092 participants, including 220 NMOSD cases, 2345 MS, and 2174 healthy subjects, were evaluated. Table 1 shows demographic and clinical features of individuals. The studied groups were statistically different in terms of marital status () and educational level (). There were significant differences between various MS courses in EDSS score () and the number of relapses in last year ().


VariablesNMOSD ()MS ()Control group () value
RRMS ()PPMS ()SPMS ()

Age0.17
Gender (M/F)24.1/75.918.2/81.845.9/54.124.1/75.929.1/78.10.12
Marital status (married/single)66.2/28.873.3/23.379.7/14.978.6/14.567.2/32.8<0.001
Education (basic/advanced)128/92957/96156/18263/901754/390<0.001
EDSS<0.001
Relapses within a previous year0.02

M: male; F: female; NMOSD: neuromyelitis optica spectrum disorders; RRMS: relapsing-remitting multiple sclerosis; PPMS: primary progressive multiple sclerosis; SPMS: secondary progressive multiple sclerosis; EDSS: Expanded Disability Status Scale. value of less than 0.05 was considered as a significant level.

Figure 1 shows birth months’ distribution in study groups. After adjusting for the year of birth, a reduced birth rate in September-October in NMOSD (, 95% CI: 0.150-0.636; ) and MS (, 95% CI: 0.374-0.591; ) compared to the general population was detected. The birth rate in March-April in MS was higher than the control group (, 95% CI: 1.324-1.964; ). There was no difference in the birth month distribution between the NMOSD and MS patients (Table 2).


MonthMS vs. controlNMOSD vs. controlMS vs. NMOSD
OR (95% CI)OR (95% CI)OR (95% CI)

March-April1.613 (1.324-1.964)<0.0011.712 (1.136-2.582)0.0101.062 (0.713-1.581)0.769
April-May1.162 (0.924-1.460)0.1991.082 (0.641-1.828)0.7670.932 (0.556-1.562)0.789
May-June1.228 (0.986-1.530)0.0660.958 (0.561-1.637)0.8760.780 (0.460-1.323)0.356
June-July0.909 (0.732-1.129)0.3891.154 (0.723-1.841)0.5491.269 (0.797-2.020)0.315
July-August1.253 (1.00-1.571)0.0501.228 (0.744-2.026)0.4230.979 (0.599-1.602)0.934
August-September1.266 (1.067-1.502)0.0071.318 (0.905-1.921)0.1501.041 (0.719-1.507)0.831
September-October0.470 (0.374-0.591)<0.0010.309 (0.150-0.636)0.0010.658 (0.317-1.363)0.260
October-November0.694 (0.522-0.921)0.0120.534 (0.246-1.163)0.1140.770 (0.353-1.681)0.512
November-December0.812 (0.637-1.035)0.0931.181 (0.716-1.948)0.5161.453 (0.881-2.397)0.143
December-January0.731 (0.576-0.927)0.0100.592 (0.316-1.109)0.1010.809 (0.431-1.519)0.510
January-February1.045 (0.812-1.345)0.7341.285 (0.757-2.180)0.3531.230 (0.729-2.073)0.438
February-March0.872 (0.692-1.098)0.2450.857 (0.495-1.485)0.5820.983 (0.568-1.700)0.950

Table 3 compares frequency and odds ratios by the MoB among different MS types and the general population. Significant increase of birth rate of RRMS patients in March-April (, 95% CI: 1.282-1.927; ) and August-September (, 95% CI: 1.103-1.567; ) and a reduction in September-October (, 95% CI: 0.378-0.614; ) compared to the reference population were found. SPMS birth rate was higher in March-April (, 95% CI: 1.260-2.493; ) and lower in September-October (, 95% CI: 0.252-0.669; ). We observed a significant increase in the birth rate in May-June (, 95% CI: 1.391-4.903; ) in PPMS compared to the control group. There was no significant difference in MOB among different MS types.

(a)

MonthRRMS vs. controlSPMS vs. controlPPMS vs. control
OR (95% CI)OR (95% CI)OR (95% CI)

March-April1.572 (1.282-1.927)<0.0011.773 (1.260-2.493)0.0011.741 (0.895-3.385)0.102
April-May1.185 (0.937-1.497)0.1561.041 (0.660-1.641)0.8620.989 (0.390-2.509)0.981
May-June1.232 (0.981-1.547)0.0731.018 (0.657-1.577)0.9362.611 (1.391-4.903)0.003
June-July0.920 (0.734-1.153)0.4700.927 (0.612-1.402)0.7180.566 (0.203-1.576)0.276
July-August1.245 (0.986-1.571)0.0651.379 (0.909-2.93)0.1311.002 (0.395-2.541)0.997
August-September1.314 (1.103-1.567)0.0021.023 (0.734-1.424)0.8950.937 (0.473-1.856)0.853
September-October0.482 (0.378-0.614)<0.0010.410 (0.252-0.669)<0.0010.513 (0.204-1.292)0.157
October-November0.714 (0.534-0.954)0.0230.454 (0.225-0.914)0.0270.991 (0.352-2.786)0.986
November-December0.793 (0.615-1.022)0.0740.914 (0.566-1.476)0.7141.214 (0.513-2.870)0.659
December-January0.747 (0.585-0.955)0.0200.614 (0.363-1.038)0.0690.879 (0.347-2.226)0.785
January-February0.962 (0.738-1.255)0.7771.656 (1.074-2.552)0.0220.981 (0.349-2.757)0.972
February-March0.861 (0.676-1.095)0.2231.068 (0.697-1.635)0.7640.331 (0.080-1.366)0.126

(b)

MonthRRMS vs. SPMSRRMS vs. PPMSSPMS vs. PPMS
OR (95% CI)OR (95% CI)OR (95% CI)

March-April1.134 (0.818-1.572)0.4501.114 (0.577-2.150)0.7470.982 (0.486-1.986)0.961
April-May0.879 (0.564-1.369)0.5680.835 (0.331-2.106)0.7030.950 (0.351-2.569)0.920
May-June0.819 (0.534-1.256)0.3602.099 (1.126-3.913)0.0202.563 (1.253-5.245)0.010
June-July1.00 (0.662-1.513)0.9980.611 (0.220-1.700)0.3450.611 (0.208-1.789)0.369
July-August1.113 (0.744-1.665)0.6020.809 (0.321-2.038)0.6520.726 (0.273-1.931)0.522
August-September0.785 (0.567-1.085)0.1430.720 (0.365-1.421)0.3430.917 (0.442-1.903)0.817
September-October0.845 (0.509-1.403)0.5161.057 (0.416-2.685)0.9081.250 (0.451-3.466)0.668
October-November0.638 (0.316-1.288)0.2101.393 (0.495-3.922)0.5302.184 (0.654-7.292)0.204
November-December1.145 (0.711-1.844)0.5781.520 (0.643-3.588)0.3401.327 (0.518-3.398)0.555
December-January0.822 (0.486-1.390)0.4641.176 (0.464-2.979)0.7321.432 (0.511-4.013)0.495
January-February1.739 (1.140-2.652)0.0101.030 (0.368-2.883)0.9550.593 (0.203-1.734)0.339
February-March1.235 (0.808-1.889)0.3290.382 (0.093-1.579)0.1840.310 (0.072-1.327)0.114

4. Discussion

In this study of the Iranian population, we found some evidence for variation in monthly birth rates in NMOSD and MS patients. Compared to control, there was a significantly increased risk of developing MS in the months of March-April. At the same time, a decreased risk for occurring NMOSD and MS in September-October was observed. These findings suggested the impact of month of birth on the development of NMOSD and MS in Iran.

Our MS patients’ birth rate increased in spring and summer and dropped sharply in September-October, remaining steady during autumn and winter. This finding accords with the recent systematic review and meta-analysis, which showed that MS births in spring are higher than in autumn [28]. A large population-based study from Canada, Great Britain, Denmark, and Sweden showed a significant increase in MS birth in May and decreased in November [29]. Previous studies from Italy [30], Scotland [31], and Finland [32] also found that the birth in spring substantially increased the risk of future MS development.

The number of birth in all MS courses reached peaks during spring. Our findings showed a different pattern of birth-month among various MS courses compared to the general population. However, we were unable to find the month of birth influence on MS phenotype. In contrast to our finding, Sadovnick and colleagues found differences in May/November birth ratios between PPMS and RRMS. This inconsistency may be due to the small number of PPMS patients in our study that limited the power of our analysis.

We next investigated the birth-month patterns in NMOSD patients. To the best of our knowledge, the birth-monthly and seasonal pattern in NMOSD patients has not been evaluated so far. The number of birth in NMOSD patients reached peaks during spring and summer and decreased in autumn.

The relation between month of birth and autoimmune diseases may partly be explained by the fetal origin of the adult disease hypothesis. According to this, exposure to seasonal factors in the perinatal period can affect embryonic or fetal tissue structures and develop physical and psychological diseases [33]. Low exposure to UVB radiation in autumn and winter can lead to vitamin D deficiency. In this period, maternal insufficient vitamin D negatively influences the fetus’ immunological and brain development. It increases the risk of lifetime MS in those born in spring and summer [3437]. A study on cord blood showed that infants born in May had greater CD4+ and CD8+ and lower 25-hydroxyvitamin D levels than those born in November [38].

In contrast to MS, there is much less information about the effect of low vitamin D on the susceptibility to NMOSD. A lower 25 (OH) D1-3 levels in NMOSD patients than the healthy controls are demonstrated [3941]. Moreover, an inverse relationship between vitamin D level and disease activity has been suggested [39, 40]. Experimental and in vitro studies have shown that vitamin D is involved in regulating both innate and acquired immunity in NMOSD [42, 43]. However, no study has evaluated the impact of inadequate vitamin D during pregnancy on the risk of NMOSD in adulthood.

Latitude and climate features are other possible factors that contribute to the monthly distribution of autoimmune diseases. Our data are consistent with those conducted in other countries in the northern hemisphere, where an increase in MS birth in spring and summer was observed [30, 44]. Both genetic and environmental factors are responsible for explaining the possible effect of latitude on autoimmunity. A systematic review found latitudinal gradient only in European-descent regions suggesting related genetic factors [45]. On the other hand, changing the likelihood of developing MS following immigration after birth shows the role of associated environmental factors. Although there is a latitude gradient for the prevalence of MS [45], no clear association between latitude and NMOSD has been found [46]. Further studies are needed to declare the relationship between latitude and NMOSD and its effect on these patients’ MoB pattern.

The pattern of MS-birth in regions with an extreme climate, similar to Isfahan, showed a substantial difference between summer and winter [47]. However, studies in countries with milder climates found no relation between MS and seasonality [15, 16]. Climate and latitude mediated this association through vitamin D and nonvitamin pathways. Individuals in regions with high latitude or cold desert climate received insufficient UVB light from autumn to winters to make vitamin D3 in their skin during these months.

Our study has some limitations. The control group was not matched with patients. However, it seems that there was no significant difference between study groups in age and sex. Our patients were enrolled from one MS center, which limited our results to other MS patients. One of the strengths of this study is adjusting for age of birth as an essential confounder [20].

In conclusion, this study provided additional support for an association between month of birth and MS development. Our findings suggest a possible association between month of birth and risk of NMOSD; however, the evidence is still insufficient to draw a certain conclusion. Because of differences between NMOSD and MS in environmental and genetic risk factors [46, 48], it is impossible to apply the suggested seasonal factors to the NMOSD population. Further studies are recommended to elucidate the relation between month of birth and disease development of NMOSD and its seasonal factors.

Data Availability

The data is available but is not included in the paper.

Disclosure

This manuscript belongs to the medical thesis. Approved ethic code: IR.MUI.MED.REC.1398.285.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

  1. D. M. Wingerchuk, V. A. Lennon, C. F. Lucchinetti, S. J. Pittock, and B. G. Weinshenker, “The spectrum of neuromyelitis optica,” The Lancet Neurology, vol. 6, no. 9, pp. 805–815, 2007. View at: Publisher Site | Google Scholar
  2. V. A. Lennon, D. M. Wingerchuk, T. J. Kryzer et al., “A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis,” The Lancet, vol. 364, no. 9451, pp. 2106–2112, 2004. View at: Publisher Site | Google Scholar
  3. I. Kawachi and H. Lassmann, “Neurodegeneration in multiple sclerosis and neuromyelitis optica,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 88, no. 2, pp. 137–145, 2017. View at: Publisher Site | Google Scholar
  4. L. Hertwig, F. Pache, S. Romero-Suarez et al., “Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica,” Multiple Sclerosis Journal, vol. 22, no. 2, pp. 160–173, 2016. View at: Publisher Site | Google Scholar
  5. H. J. Kim, F. Paul, M. A. Lana-Peixoto et al., “MRI characteristics of neuromyelitis optica spectrum disorder: an international update,” Neurology, vol. 84, no. 11, pp. 1165–1173, 2015. View at: Publisher Site | Google Scholar
  6. A. E. Handel, G. Giovannoni, G. C. Ebers, and S. V. Ramagopalan, “Environmental factors and their timing in adult-onset multiple sclerosis,” Nature Reviews Neurology, vol. 6, no. 3, pp. 156–166, 2010. View at: Publisher Site | Google Scholar
  7. S. Simpson, L. Blizzard, P. Otahal, I. Van der Mei, and B. Taylor, “Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 82, no. 10, pp. 1132–1141, 2011. View at: Publisher Site | Google Scholar
  8. U. Givon, G. Zeilig, M. Dolev, and A. Achiron, “The month of birth and the incidence of multiple sclerosis in the Israeli population,” Neuroepidemiology, vol. 38, no. 1, pp. 64–68, 2012. View at: Publisher Site | Google Scholar
  9. R. Dobson, G. Giovannoni, and S. Ramagopalan, “The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 84, no. 4, pp. 427–432, 2013. View at: Publisher Site | Google Scholar
  10. H. S. Kahn, T. M. Morgan, L. D. Case et al., “Association of type 1 diabetes with month of birth among U.S. youth: the SEARCH for Diabetes in Youth Study,” Diabetes Care, vol. 32, no. 11, pp. 2010–2015, 2009. View at: Publisher Site | Google Scholar
  11. G. E. Krassas, K. Tziomalos, N. Pontikides, H. Lewy, and Z. Laron, “Seasonality of month of birth of patients with Graves’ and Hashimoto’s diseases differ from that in the general population,” European Journal of Endocrinology, vol. 156, no. 6, pp. 631–636, 2007. View at: Publisher Site | Google Scholar
  12. G. Salemi, P. Ragonese, P. Aridon et al., “Is season of birth associated with multiple sclerosis?” Acta Neurologica Scandinavica, vol. 101, no. 6, pp. 381–383, 2000. View at: Publisher Site | Google Scholar
  13. Y. D. Fragoso, T. Adoni, S. M. G. Almeida et al., “Multiple sclerosis in South America: month of birth in different latitudes does not seem to interfere with the prevalence or progression of the disease,” Arquivos de Neuro-Psiquiatria, vol. 71, no. 9A, pp. 573–579, 2013. View at: Publisher Site | Google Scholar
  14. A. Watad, S. Azrielant, A. Soriano, D. Bracco, A. Abu Much, and H. Amital, “Association between seasonal factors and multiple sclerosis,” European Journal of Epidemiology, vol. 31, no. 11, pp. 1081–1089, 2016. View at: Publisher Site | Google Scholar
  15. S. Akhtar, R. Alroughani, A. Al-Shammari, J. Al-Abkal, and Y. Ayad, “Non-parametric analysis of seasonality in birth and multiple sclerosis risk in second generation of migrants in Kuwait,” BMC Neurology, vol. 14, no. 1, p. 170, 2014. View at: Publisher Site | Google Scholar
  16. Y. D. Fragoso, K. D. Shearer, T. Adoni et al., “Month of birth does not seem to interfere with the development of multiple sclerosis later in life in Brazilian patients,” Neuroepidemiology, vol. 39, no. 1, pp. 70-71, 2012. View at: Publisher Site | Google Scholar
  17. P. Barros, J. M. de Sá, and M. J. Sá, “Month of birth and risk of multiple sclerosis in a Portuguese population,” Clinical Neurology and Neurosurgery, vol. 115, no. 9, pp. 1762–1765, 2013. View at: Publisher Site | Google Scholar
  18. N.-K. Walleczek, F. Frommlet, G. Bsteh et al., “Month-of-birth-effect in multiple sclerosis in Austria,” Multiple Sclerosis Journal, vol. 25, no. 14, pp. 1870–1877, 2019. View at: Publisher Site | Google Scholar
  19. O. Eliasdottir, A. Hildeman, M. Longfils, O. Nerman, and J. Lycke, “A nationwide survey of the influence of month of birth on the risk of developing multiple sclerosis in Sweden and Iceland,” Journal of Neurology, vol. 265, no. 1, pp. 108–114, 2018. View at: Publisher Site | Google Scholar
  20. B. Fiddes, J. Wason, A. Kemppinen, M. Ban, A. Compston, and S. Sawcer, “Confounding underlies the apparent month of birth effect in multiple sclerosis,” Annals of Neurology, vol. 73, no. 6, pp. 714–720, 2013. View at: Publisher Site | Google Scholar
  21. O. Torkildsen, J. Aarseth, E. Benjaminsen et al., “Month of birth and risk of multiple sclerosis: confounding and adjustments,” Annals of Clinical and Translational Neurology, vol. 1, no. 2, pp. 141–144, 2014. View at: Publisher Site | Google Scholar
  22. O. Mirmosayyeb, S. Brand, M. Barzegar et al., “Clinical characteristics and disability progression of early- and late-onset multiple sclerosis compared to adult-onset multiple sclerosis,” Journal of Clinical Medicine, vol. 9, no. 5, p. 1326, 2020. View at: Publisher Site | Google Scholar
  23. A. J. Thompson, B. L. Banwell, F. Barkhof et al., “Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria,” The Lancet Neurology, vol. 17, no. 2, pp. 162–173, 2018. View at: Publisher Site | Google Scholar
  24. C. H. Polman, S. C. Reingold, B. Banwell et al., “Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria,” Annals of Neurology, vol. 69, no. 2, pp. 292–302, 2011. View at: Publisher Site | Google Scholar
  25. C. H. Polman, S. C. Reingold, G. Edan et al., “Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”,” Annals of Neurology, vol. 58, no. 6, pp. 840–846, 2005. View at: Publisher Site | Google Scholar
  26. D. M. Wingerchuk, B. Banwell, J. L. Bennett et al., “International consensus diagnostic criteria for neuromyelitis optica spectrum disorders,” Neurology, vol. 85, no. 2, pp. 177–189, 2015. View at: Publisher Site | Google Scholar
  27. J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurology, vol. 33, no. 11, pp. 1444–1452, 1983. View at: Publisher Site | Google Scholar
  28. K. G. Pantavou and P. G. Bagos, “Season of birth and multiple sclerosis: a systematic review and multivariate meta-analysis,” Journal of Neurology, vol. 267, pp. 1–8, 2019. View at: Publisher Site | Google Scholar
  29. C. J. Willer, D. A. Dyment, A. D. Sadovnick et al., “Timing of birth and risk of multiple sclerosis: population based study,” BMJ, vol. 330, no. 7483, p. 120, 2005. View at: Publisher Site | Google Scholar
  30. S. Sotgiu, M. Pugliatti, M. A. Sotgiu et al., “Seasonal fluctuation of multiple sclerosis births in Sardinia,” Journal of Neurology, vol. 253, no. 1, pp. 38–44, 2006. View at: Publisher Site | Google Scholar
  31. H. K. Bayes, C. J. Weir, and C. O’Leary, “Timing of birth and risk of multiple sclerosis in the Scottish population,” European Neurology, vol. 63, no. 1, pp. 36–40, 2010. View at: Publisher Site | Google Scholar
  32. K.-P. Saastamoinen, M.-K. Auvinen, and P. J. Tienari, “Month of birth is associated with multiple sclerosis but not with HLA-DR15 in Finland,” Multiple Sclerosis Journal, vol. 18, no. 5, pp. 563–568, 2012. View at: Publisher Site | Google Scholar
  33. D. J. P. Barker, “The Wellcome Foundation Lecture, 1994. The fetal origins of adult disease,” Proceedings of the Royal Society of London Series B: Biological Sciences, vol. 262, no. 1363, pp. 37–43, 1995. View at: Publisher Site | Google Scholar
  34. K. L. Munger, J. Åivo, K. Hongell, M. Soilu-Hänninen, H.-M. Surcel, and A. Ascherio, “Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish Maternity Cohort,” JAMA Neurology, vol. 73, no. 5, pp. 515–519, 2016. View at: Publisher Site | Google Scholar
  35. F. Mirzaei, K. B. Michels, K. Munger et al., “Gestational vitamin D and the risk of multiple sclerosis in offspring,” Annals of Neurology, vol. 70, no. 1, pp. 30–40, 2011. View at: Publisher Site | Google Scholar
  36. P. Koduah, F. Paul, and J.-M. Dörr, “Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases,” Epma Journal, vol. 8, no. 4, pp. 313–325, 2017. View at: Publisher Site | Google Scholar
  37. J. Staples, A.-L. Ponsonby, and L. Lim, “Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis,” BMJ, vol. 340, 2010. View at: Google Scholar
  38. G. Disanto, C. T. Watson, U. C. Meier, G. C. Ebers, G. Giovannoni, and S. V. Ramagopalan, “Month of birth and thymic output,” JAMA Neurology, vol. 70, no. 4, pp. 527-528, 2013. View at: Publisher Site | Google Scholar
  39. J.-H. Min, P. Waters, A. Vincent et al., “Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability,” PLoS One, vol. 9, no. 9, article e107274, 2014. View at: Publisher Site | Google Scholar
  40. Y. Shan, S. Tan, L. Zhang et al., “Serum 25-hydroxyvitamin D3 is associated with disease status in patients with neuromyelitis optica spectrum disorders in South China,” Journal of Neuroimmunology, vol. 299, pp. 118–123, 2016. View at: Publisher Site | Google Scholar
  41. M. A. Mealy, S. Newsome, B. M. Greenberg, D. Wingerchuk, P. Calabresi, and M. Levy, “Low serum vitamin D levels and recurrent inflammatory spinal cord disease,” Archives of Neurology, vol. 69, no. 3, pp. 352–356, 2012. View at: Publisher Site | Google Scholar
  42. S. Chen, G. P. Sims, X. X. Chen, Y. Y. Gu, S. Chen, and P. E. Lipsky, “Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation,” The Journal of Immunology, vol. 179, no. 3, pp. 1634–1647, 2007. View at: Publisher Site | Google Scholar
  43. Y. Wu, Y. Cai, M. Liu, D. Zhu, and Y. Guan, “The potential immunoregulatory roles of vitamin D in neuromyelitis optica spectrum disorder,” Multiple Sclerosis and Related Disorders, vol. 43, article 102156, 2020. View at: Publisher Site | Google Scholar
  44. D. Templer, N. Trent, D. Spencer et al., “Season of birth in multiple sclerosis,” Acta Neurologica Scandinavica, vol. 85, no. 2, pp. 107–109, 1992. View at: Publisher Site | Google Scholar
  45. S. Simpson, W. Wang, P. Otahal, L. Blizzard, I. A. van der Mei, and B. V. Taylor, “Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 90, no. 11, pp. 1193–1200, 2019. View at: Publisher Site | Google Scholar
  46. M. Mori, S. Kuwabara, and F. Paul, Worldwide prevalence of neuromyelitis optica spectrum disorders, BMJ Publishing Group Ltd., 2018.
  47. R. N. Villar-Quiles, J. A. Matías-Guiu, G. Ortega, I. González-Suárez, C. Oreja-Guevara, and J. Matías-Guiu, “Analysis of the relationship between the month of birth and risk of multiple sclerosis in a Spanish population,” European Neurology, vol. 76, no. 5-6, pp. 202–209, 2016. View at: Publisher Site | Google Scholar
  48. M. Watanabe, Y. Nakamura, S. Sato et al., “HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data,” Scientific Reports, vol. 11, no. 1, p. 607, 2021. View at: Publisher Site | Google Scholar

Copyright © 2021 Omid Mirmosayyeb et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views633
Downloads740
Citations

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.